Advancing cellular health through science
Longevity Life Sciences is an Australian life sciences company translating emerging cellular science into evidence-led ingredients, proprietary formulations and advanced health solutions.
Our work spans scientific research, ingredient innovation, regulatory strategy, advanced formulation and commercialisation — creating the pathways required to move promising science from discovery to real-world application.
Healthier lives begin with healthier cells.
As our understanding of human biology advances, so too does our ability to understand and support the cellular processes that help maintain healthy function throughout life.
At Longevity Life Sciences, we believe some of the most important opportunities in health will come from translating this emerging science into evidence-led solutions that can reach people at scale.
Science Regulation Translation Scale
Longevity Life Sciences was founded on a simple premise: promising science only creates meaningful impact when it can be rigorously validated, responsibly translated and successfully brought to market.
Our model brings together scientific research, ingredient innovation, regulatory strategy, advanced formulation, manufacturing and commercialisation within one connected ecosystem.
This allows us to identify promising areas of cellular science, build the evidence and regulatory pathways around them, and work with leading researchers, biotechnology companies, manufacturers and health organisations to translate that science into real-world applications.
We believe the strongest innovations are not built around trends. They are built through better science, disciplined translation, and trusted partnerships.
The science of cellular health is advancing rapidly. Our role is to identify what matters, build the evidence around it and create responsible pathways for that science to reach people at scale.
Our ambition
Our ambition is to build CellVive® into one of the world’s most trusted cellular-health platforms — advancing the science, technologies and solutions that support healthier cells and, ultimately, healthier lives.
Leadership
Built to translate science into impact
Our leadership team brings together experience across life sciences, healthcare, commercialisation, finance, operations and global market development.
Together, we are building the scientific, regulatory and commercial capabilities required to translate emerging cellular science into evidence-led solutions at scale.
-
Sally Panton
Co-Founder & Chief Executive Officer
Read bio
Sally Panton is Co-Founder and Chief Executive Officer of Longevity Life Sciences. She has more than 15 years of experience spanning healthcare, technology, commercialisation and company building, with a focus on bringing emerging health innovations to market. At Longevity Life Sciences, Sally leads corporate strategy, partnerships, capital and the company’s long-term vision to build a globally relevant cellular-health platform.
-
Lucy Canny
Co-Founder & Chief Operating Officer
Read bio
Lucy Canny is Co-Founder and Chief Operating Officer of Longevity Life Sciences. She leads the operational execution of the business across commercialisation, regulatory programs, strategic partnerships and international market development, with a focus on translating scientific innovation into commercial opportunities. At Longevity Life Sciences, Lucy drives new partnerships and the expansion of the CellVive® platform, building the capabilities required to bring emerging cellular health innovations to market.
-
Matt Prent
Chief Financial Officer
Read bio
Matt Prent is Chief Financial Officer of Longevity Life Sciences, overseeing the company’s financial strategy, capital management, governance and commercial planning. He brings extensive experience across corporate finance, investment and strategic advisory, supporting the financial discipline and infrastructure required for the company’s next phase of growth. Matt works closely with the executive team on capital allocation, strategic partnerships, investment and long-term value creation.
-
Colin Armstrong
Head of Global Markets (Advisor)
Read bio
Colin Armstrong leads commercial strategy and global market development at Longevity Life Sciences. He brings extensive experience across consumer health and international markets, with a strong track record in building strategic partnerships, driving commercial growth and scaling health brands and technologies globally. At Longevity Life Sciences, Colin leads commercial growth, strategic partnerships and international expansion, supporting the continued development and global reach of the CellVive® platform.
-
Ed Myer
Director
Read bio
Ed Myer is a Director of Longevity Life Sciences and an experienced investor and business executive with a background spanning financial markets, private investment, technology and healthcare. He is Co-Founder of Myer Walker, an investment company focused on identifying, investing in and supporting high-growth businesses with long-term strategic potential. Ed previously held investment and operating roles across the Myer Family’s Yulgilbar Group and has worked across global financial markets in Australia, Hong Kong and internationally. Ed is also an independent Non-Executive Director of ASX-listed Bioxyne Limited and Chair of its Audit & Finance Committee. At Longevity Life Sciences, Ed brings expertise across governance, capital allocation, corporate strategy and value creation, working closely with the executive team as the company expands its scientific platform, commercial partnerships and international presence.
Scientific, medical & strategic advisors
A multidisciplinary approach to cellular health
Our work is supported by experts spanning clinical pharmacology, pharmaceutical science, nutrition, medicine, regulatory affairs, health economics and market access.
Together, they bring scientific, medical and strategic perspective across research, clinical development, regulation and the translation of emerging science into real-world health applications.
-
Dr Beata Silber
BA (Hons), PhD, Marie Curie Postdoctoral Fellow
Read bio
A neurocognitive scientist and global R&D leader with nearly three decades of experience across international research institutes and large global health and wellness organisations, translating emerging science into clinically substantiated, commercially successful consumer health and wellness products.
Beata has led multidisciplinary scientific teams, with expertise spanning product development, clinical research, scientific claims and portfolio strategy. She partners with executive teams and Boards to build scientific credibility, guide innovation investment and create trusted, differentiated global brands.
As Chief Scientific Officer of Longevity Life Sciences, Dr Beata Silber leads the company’s scientific strategy. She helps ensure the company’s innovation pipeline is grounded in rigorous science, working closely with Longevity Life Sciences’ research, clinical and industry partners to translate emerging scientific opportunities into evidence-led development programs.
-
Dr Teresa Nicoletti
BSc (Hons), PhD, DipLaw
Read bio
Dr Teresa Nicoletti is a lawyer and PhD-qualified scientist and Partner at Mills Oakley, where she leads the Health and Life Sciences practice. A recognised authority on therapeutic goods regulation, she advises Longevity Life Sciences on regulatory strategy, compliance, governance and pathways across complementary and prescription medicines.
-
Associate Professor Sophie Stocker
BSc, PhD
Read bio
Associate Professor Sophie Stocker is a clinical pharmacologist and academic at the University of Sydney’s School of Pharmacy. Her research focuses on clinical pharmacology, precision dosing and variability in medicine response. At Longevity Life Sciences, she provides scientific oversight and expertise across clinical trial design, pharmacology and translational research.
-
Dr Ross Walker
MBBS (Hons), FRACP, FCSANZ
Read bio
Dr Ross Walker is a practising cardiologist with more than 45 years of clinical experience and a recognised voice in preventative cardiology. As a medical advisor to Longevity Life Sciences, he brings expertise in cardiovascular health, preventative medicine and the translation of emerging science into responsible health applications.
-
George Papadopoulos
BSc (Hons), GradDipEpi, MAICD
Read bio
George Papadopoulos is a health economist and strategic market access specialist with more than 25 years of experience across the global pharmaceutical industry. He provides Longevity Life Sciences with expertise across health economics, reimbursement, health technology assessment and market access, helping shape evidence-to-access strategies for emerging health innovations.
-
Kathryn Williams
Senior Market Access Specialist
Read bio
Kathryn Williams is a global regulatory and market access strategist with extensive experience guiding biotechnology companies through complex international regulatory pathways. She supports Longevity Life Sciences in regulatory foresight and global expansion strategy, helping align science-led innovation with international regulatory requirements and pathways to market.
-
Professor Kamal Dua
BPharm, MPharm, PhD
Read bio
Professor Kamal Dua is a pharmaceutical scientist and immunologist with expertise in advanced drug delivery and translational therapeutics. A senior academic at the University of Technology Sydney and Adjunct Fellow at the NICM Health Research Institute, his work spans innovative formulation science, immunology and evidence-based approaches to natural and complementary medicines. As an advisor to Longevity Life Sciences, he provides expertise across formulation, drug delivery and translational research.
-
Dr Brad McEwen
PhD, MHSc (HumNutr), MPH, BHSc
Read bio
Dr Brad McEwen is a nutrition scientist and naturopath with more than 20 years of clinical and research experience. His work examines the relationship between nutrition, lifestyle and healthy ageing. As an advisor to Longevity Life Sciences, he provides expertise in nutritional biochemistry, scientific evidence and research and product development.
Partner with Longevity Life Sciences
We work with researchers, biotechnology companies, ingredient innovators, manufacturers, health brands, retailers and strategic partners around the world.
For research collaborations, ingredient partnerships, regulatory and commercial opportunities, or to explore working with Longevity Life Sciences, contact our team.